Literature DB >> 32576479

The prognostic role of the preoperative systemic immune-inflammation index and high-sensitivity modified Glasgow prognostic score in patients after radical operation for soft tissue sarcoma.

Tao Hou1, Tianhui Guo2, Runcong Nie3, Dongchun Hong2, Zhiwei Zhou3, Xing Zhang4, Yao Liang5.   

Abstract

INTRODUCTION: The prognostic values of nutritional and immune-inflammatory indicators in non-metastatic soft tissue sarcoma (STS) patients are not clear. We investigated the utility of systemic immune-inflammation index (SII) and the high-sensitivity modified Glasgow prognostic score (Hs-mGPS) in the prediction of STS patient's prognosis.
MATERIALS AND METHODS: Patients admitted between January 2000 and December 2016, who underwent R0 resection for STS at SYSUCC were carefully retrospectively reviewed, and 454 patients were enrolled. The laboratory data and clinical data were collected from the patient's record. ROC analysis is used to determine the optimal cutoff value. Survival curves were analysed by Kaplan-Meier method. Cox proportional hazard model was used to find out prognostic variables.
RESULTS: Increased SII and Hs-mGPS values were significantly related to larger tumour size, deep tumour location, higher tumour grade and more advanced American Joint Committee on Cancer (AJCC) stage. Patients with an elevated SII had a shorter median survival time and a lower 5-year OS rate than those with a low SII. And patients with low Hs-mGPS had longer median OS and DFS. Multivariate analysis revealed that both the SII and the Hs-mGPS were independent predictive indicators for OS. And a joint model containing both the Hsm-GPS and the SII appeared to have the strongest predictive ability.
CONCLUSION: Our findings indicated that malnutrition and systemic inflammation are risk factors for the survival of STS patients after operation, and early recognition and intervention of malnutrition and systemic inflammation may help to improve the survival of the patients.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Hs-mGPS; Prognostic factors; SII; Soft tissue sarcoma; Survival

Mesh:

Year:  2020        PMID: 32576479     DOI: 10.1016/j.ejso.2020.05.026

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score.

Authors:  Tomoki Nakamura; Kunihiro Asanuma; Tomohito Hagi; Akihiro Sudo
Journal:  J Inflamm Res       Date:  2022-07-11

2.  Predictive Value of Preoperative Controlling Nutritional Status Score Combined with Fibrinogen-Albumin Ratio in Postoperative Local Recurrence-Free Survival of Patients with Retroperitoneal Liposarcoma.

Authors:  Guo-Qiang Xue; Cheng-Peng Li; Ang Lv; Xiu-Yun Tian; Jian-Hui Wu; Hui Qiu; Chun-Yi Hao
Journal:  Cancer Manag Res       Date:  2021-08-06       Impact factor: 3.989

3.  Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients.

Authors:  Yifang Shui; Mengquan Li; Jing Su; Mingxun Chen; Xiaobin Gu; Wenzhi Guo
Journal:  Aging (Albany NY)       Date:  2021-08-25       Impact factor: 5.682

4.  Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study.

Authors:  Yao-Te Tsai; Ku-Hao Fang; Cheng-Ming Hsu; Chia-Hsuan Lai; Sheng-Wei Chang; Ethan I Huang; Ming-Shao Tsai; Geng-He Chang; Chih-Wei Luan
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

5.  Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors.

Authors:  Rui Huang; Yanfen Zheng; Wenxue Zou; Chao Liu; Jibing Liu; Jinbo Yue
Journal:  J Immunol Res       Date:  2022-08-17       Impact factor: 4.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.